| Host: |
E. coli |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-Human BID-C-His protein was developed from e. coli and has a target region of C-His. For use in research applications. |
| Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of 50mM TRIS, 150mM NaCl, pH 8.0. Contact us for customized product form or formulation. |
| Immunoreactivity: |
Measured by its binding ability in a functional ELISA. Immobilized Human BID at 2 Mu g/mL (100 Mu L/well) can bind BCL-XL with a linear range of 0.195-4.94 ng/mL. |
| Gene Symbol: |
BID |
| Gene ID: |
637 |
| Uniprot ID: |
BID_HUMAN |
| Immunogen Region: |
Met1-Asp195 |
| Immunogen: |
Recombinant Human BID Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Asp195) of human BID (Accession #NP_001187.1) fused with a 6×His tag at the C-terminus. |
| Tissue Specificity | Isoform 2: Expressed in spleen, pancreas and placenta (at protein level). Isoform 3: Expressed in lung, pancreas and spleen (at protein level). Isoform 4: Expressed in lung and pancreas (at protein level). |
| Post Translational Modifications | BH3-interacting domain death agonist: TNF-alpha induces caspase-mediated cleavage into a major p15 and minor p13 and p11 products. Cleaved by CASP6 into a major p15 and minor p13 products, leading to release of cytochrome c and subsequent nonalcoholic steatohepatitis. BH3-interacting domain death agonist p15: Ubiquitinated by ITCH.ubiquitination results in proteasome-dependent degradation. |
| Function | Induces caspases and apoptosis. Counters the protective effect of BCL2. BH3-interacting domain death agonist p15: Induces caspase activation and apoptosis. Allows the release of cytochrome c. Isoform 1: Induces ICE-like proteases and apoptosis. Isoform 2: Induces ICE-like proteases and apoptosis. Isoform 3: Does not induce apoptosis. Isoform 4: Induces ICE-like proteases and apoptosis. |
| Protein Name | Bh3-Interacting Domain Death AgonistP22 BidBid Cleaved Into - Bh3-Interacting Domain Death Agonist P15P15 Bid - Bh3-Interacting Domain Death Agonist P13P13 Bid - Bh3-Interacting Domain Death Agonist P11P11 Bid |
| Database Links | Reactome: R-HSA-111447Reactome: R-HSA-111452Reactome: R-HSA-111453Reactome: R-HSA-114294Reactome: R-HSA-6803204Reactome: R-HSA-75108 |
| Cellular Localisation | CytoplasmMitochondrion MembraneMitochondrion Outer MembraneWhen UncleavedIt Is Predominantly CytoplasmicBh3-Interacting Domain Death Agonist P15: Mitochondrion MembraneTranslocates To Mitochondria As An Integral Membrane ProteinBh3-Interacting Domain Death Agonist P13: Mitochondrion MembraneAssociated With The Mitochondrial MembraneIsoform 1: CytoplasmIsoform 3: CytoplasmIsoform 2: Mitochondrion MembraneA Significant Proportion Of Isoform 2 Localizes To MitochondriaIt May Be Cleaved Constitutively |
| Alternative Protein Names | Bh3-Interacting Domain Death Agonist proteinP22 Bid proteinBid Cleaved Into - Bh3-Interacting Domain Death Agonist P15 proteinP15 Bid - Bh3-Interacting Domain Death Agonist P13 proteinP13 Bid - Bh3-Interacting Domain Death Agonist P11 proteinP11 Bid proteinBID protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
